Drug Type Small molecule drug |
Synonyms S 1746, SB 737005, SB-737005 |
Action antagonists, modulators |
Mechanism AMPA receptor antagonists(Glutamate receptor ionotropic AMPA antagonists), NMDA receptor modulators(Glutamate [NMDA] receptor modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC14H8N6O4 |
InChIKeyADPHGDUUADGFSX-UHFFFAOYSA-N |
CAS Registry251919-00-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Ischemic Stroke | Phase 1 | United States | 31 Mar 2003 | |
Acute Ischemic Stroke | Phase 1 | Japan | 31 Mar 2003 |